From May 20–23, APT Medical wrapped up its successful participation at EuroPCR 2025, the world-leading course in interventional cardiovascular medicine, held in Paris. The event brought together over 12,000 participants to explore the latest advancements and trends in interventional therapies.

This year, APT Medical expanded its presence with a larger booth showcasing its comprehensive PCI product portfolio. Notably, the company sponsored the "Training Village" for the first time, hosting a series of educational workshops that underscored its commitment to product innovation, clinical education, and global collaboration.

Training Village Workshops Spotlight Complex PCI Strategies and Global Expertise

To support physicians in enhancing procedural skills and clinical strategies for complex interventions, APT Medical organized six themed workshops at the Training Village, covering key topics such as CTO PCI, Complex PCI, and distal radial access.

We invited ten renowned interventional cardiologists from the UK, Italy, China, Switzerland, Türkiye, France, Spain, and Greece as speakers, sharing insights and best practices with international physicians. Among the highlights, the CTO PCI topics drew exceptional interest, with full attendance and strong engagement.

Over the course of three days, the APT Training Village welcomed more than 130 physicians, reflecting the company's growing recognition and established expertise in clinical education and interventional technologies. Following each session, the speakers also conducted live demonstrations of APT’s core products, further showcasing the performance and clinical advantages of its complex PCI solutions.

Active Booth Engagement and Strong Interest in CTO Solution

Beyond the Training Village, APT Medical showcased its comprehensive products and solutions in Interventional cardiology at the booth, drawing continuous foot traffic from physicians, academic experts, and industry partners from across the globe.

APT Medical’s CTO solution, in particular, gained significant attention thanks to its outstanding performance and positive clinical feedback, demonstrating APT Medical’s growing strength in complex coronary intervention technologies.

Expanding Global Collaboration through Innovation

EuroPCR 2025 served not only as a platform for APT Medical to showcase its latest innovations but also as a meaningful opportunity to connect with international experts, strengthen clinical partnerships, and enhance global recognition of the company’s technologies and values.

Looking ahead, APT Medical remains committed to innovation-driven development and will continue to expand its international partnerships—working alongside medical professionals worldwide to advance the future of interventional medicine.